LDLydia J. Davis

Lydia J. Davis

*This is an algorithmically generated author record based on publicly available information.

Lydia J. Davis has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Discovery of Suomilide and Cyanopeptolin Analogues by 15 N Stable Isotope Labeling and Genome Mining of Cyanobacteria

    by Isabel M. Chauvin, Lydia J. Davis, Aleksej Krunic, Jimmy Orjala

    Cyanobacteria have been a promising source for natural product drug discovery for decades using mainly activity-guided approaches. More recently, genome mining and bioinformatics-guided approaches have become increasingly utilized in bacterial drug discovery and have proven to be successful in revealing novel metabolites predicted by biosynthetic gene clusters. However, detection and identification of these predicted metabolites can be difficult. Connecting nitrogen-containing natural products with the corresponding gene clusters encoding them in cyanobacteria can be aided by cyanobacteria's ability to incorporate inorganic nitrogen into their secondary metabolites. Feeding cyanobacteria with 15N-labeled and 14N nitrate and comparing the resulting metabolic profiles via mass spectrometry allows for the identification of nitrogen-containing metabolites, which can then be connected to biosynthetic gene clusters. Investigation of Nostoc sp. UIC 10890 using this workflow identified 28 total gene clusters and five groups of masses incorporating 15N-labeled nitrogen. Two of these groups contained new compounds, and the structures were elucidated by NMR and MS/MS. Three new compounds suomilide F, cyanopeptolin UIC949, and cyanopeptolin UIC999 were shown to have inhibitory activity against different serine proteases.


  • Menominin A and B: Cytotoxic Cyclodepsipeptides from the Freshwater Sponge-Associated Cyanobacterium Nostoc sp. UIC 10607

    by Lydia J. Davis, Aleksej Krunić, Kelsey Alexander, Manead Khin, Jared S. Wood, Cody Earp, Manuel Rangel-Grimaldo, Alessandra S. Eustáquio, Joanna E. Burdette, R. Thomas Williamson, et al.

    Menominin A (1) and B (2), two cyclodepsipeptides containing a 3,8-dihydroxy-2-methyltetradecanoic acid residue, were isolated from the freshwater sponge-associated cyanobacterium, Nostoc sp. UIC 10607, using bioactivity-guided and spectroscopic approaches. The planar structures of 1 and 2 were established using HRESIMS and one- and two-dimensional NMR experiments. Comparative genomic analysis revealed unique differences in the putative menominin biosynthetic gene cluster compared to that of the closely related cyanobacterial cyclic lipodepsipeptide, hapalosin, assisting in structure elucidation and highlighting the structural diversity of this class of compounds. Configuration assignments were determined using a combination of J-based configuration analysis, chiral HPLC, modified Mosher's ester analysis, and DFT calculations. Menominin A and B demonstrate antiproliferative bioactivity against the high-grade serous ovarian cancer cell line OVCAR3 (IC50 = 3.1 (1) and 2.4 μM (2)). Menominin A and B are the first reported secondary metabolites from a freshwater sponge-associated cyanobacterium, underscoring the potential of freshwater sponges as a microbial culture source in natural product discovery.


  • Aulosirazole Stimulates FOXO3a Nuclear Translocation to Regulate Apoptosis and Cell-Cycle Progression in High-Grade Serous Ovarian Cancer (HGSOC) Cells

    by Manead Khin, Lydia J. Davis, Daniel D. Lantvit, Jimmy Orjala, Joanna E. Burdette

    Ovarian cancer, the fifth leading cause of cancer-related mortality in women, is the most lethal gynecological malignancy globally. Within various ovarian cancer subtypes, high-grade serous ovarian cancer (HGSOC) is the most prevalent and there is frequent emergence of chemoresistance. Aulosirazole, an isothiazolonaphthoquinone alkaloid, isolated from the cyanobacterium Nostoc sp. UIC 10771, demonstrated cytotoxic activity against OVCAR3 cells (IC50 = 301 {plus minus} 80 nM). Using immunocytochemistry, OVCAR3 cells treated with aulosirazole demonstrated increased concentrations of pAKT and pJNK with subsequent accumulation of FOXO3a in the nucleus. The combination of aulosirazole with AKT inhibitors resulted in the most nuclear accumulation of FOXO3a Aulosirazole induced apoptosis based on cleavage of PARP, Annexin V staining, and induction of caspase 3/7 activity in OVCAR3, OVCAR5 and OVCAR8. The expression of downstream targets of FOXO3a, including BCL2 and PUMA, significantly increased following aulosirazole treatment. Aulosirazole upregulated the FOXO3a target, p21, and increased cell cycle arrest in the G0/G1 phase. The downregulation of FOXO3a by shRNA reduced the cytotoxicity after aulosirazole treatment by threefold IC50 (949 {plus minus} 16 nM) and eliminated its ability to regulate downstream targets of FOXO3a. These findings underscore FOXO3a as a critical mediator of aulosirazole-induced cytotoxicity. Additionally, aulosirazole was able to decrease migration and invasion while increasing cell death in3D tumor spheroids. However, in vivo OVCAR8 tumor burden was not significantly reducedby aulosirazole using an intraperitoneal tumor model. Given the mechanism of action of aulosirazole, this class of alkaloids represents promising lead compounds to develop treatments against FOXO3a-downregulated cancers. Significance Statement Aulosirazole, an isothiazolonaphthoquinone alkaloid, exhibits potent cytotoxic effects against HGSOC by promoting FOXO3a nuclear accumulation and modulating downstream targets. These findings highlight the potential of aulosirazole as a promising therapeutic intervention for cancers characterized by FOXO3a downregulation.


  • Aulosirazoles B and C from the Cyanobacterium Nostoc sp. UIC 10771: Analogues of an Isothiazolonaphthoquinone Scaffold that Activate Nuclear Transcription Factor FOXO3a in Ovarian Cancer Cells

    by Lydia J. Davis, Amanda C. Maldonado, Manead Khin, Aleksej Krunic, Joanna E. Burdette, Jimmy Orjala

    The known solid-tumor-selective cytotoxin aulosirazole (1) was identified from bioactive extracts from the culture medium of the cyanobacterium Nostoc sp. UIC 10771. Here, we demonstrate that 1 induces the nuclear accumulation of FOXO3a in OVCAR3 using both Western blot analysis and immunofluorescence confocal microscopy. We also report the discovery of two additional analogues, aulosirazoles B (2) and C (3). Structures for compounds 2 and 3 were determined using HR-ESI-LC-MS/MS and 1D and 2D NMR experiments. Aulosirazoles B (2) and C (3) represent the first natural analogues of the FOXO-activating compound aulosirazole (1) and are the second and third isothiazole-containing metabolites reported from this phylum.